CenExel Welcomes Dr. Arun Singh to Lead Toms River Clinical Research Hub
On April 29, 2026, CenExel, a prominent network of clinical research sites, announced the appointment of Dr. Arun Singh, DO, as the primary Principal Investigator for their Toms River location. This site stands as a beacon of clinical research excellence, particularly focused on Alzheimer's disease and related neurological conditions.
Dr. Singh, who joined the former Advanced Memory Research Institute in September 2019, has played a pivotal role in conducting groundbreaking research aimed at addressing Alzheimer's disease. His background is robust; after graduating from Rutgers University, he attended Rowan Medical School, subsequently becoming a board-certified Emergency Medicine physician at Ocean Medical Center in Brick, New Jersey. This unique blend of experience equips Dr. Singh perfectly for his new leadership role at the Toms River site.
As the primary Principal Investigator, Dr. Singh's responsibilities encompass a wide array of critical functions essential for successful clinical trials. These include ensuring patient safety, guaranteeing the quality of care provided during trials, executing protocols, managing site operations, and fostering collaboration with sponsors and research teams. His leadership is crucial for maintaining the site’s reputation for excellence in clinical research.
"I am honored to lead the Toms River site," Dr. Singh stated in a press release. "CenExel is renowned for its excellence in the research space, and I look forward to continuing that with the team and expanding access to research opportunities for our patient population." His vision aligns seamlessly with CenExel's mission to enhance research access and bolster its presence in New Jersey, particularly addressing pressing health concerns like Alzheimer’s.
The Toms River site is auspiciously positioned as the largest Alzheimer's disease clinical research site in the Northeast, marking it as a significant player in the field of memory disorder research. With its expansive scale, expert staff, and deep patient connections, it serves as a vital component of CenExel's growing clinical research network.
CenExel itself has gained a reputation as a leading entity in supporting the life sciences industry through the discovery and development of transformative therapies. Their commitment is reflected in their comprehensive approach to clinical trials, where they blend scientific expertise with world-class Principal Investigators, advanced patient engagement strategies, and superior data management.
Having conducted thousands of studies with a focus on quality and efficiency, CenExel locations, including Toms River, ensure that research projects are executed quickly and accurately. Their unwavering commitment to patient experience and client success underscores the company’s dedication to delivering impactful clinical outcomes.
With Dr. Arun Singh at the helm, the Toms River site is poised for significant advancements in Alzheimer's research and clinical trials, ultimately contributing to better patient outcomes at both the local and national levels. To learn more about CenExel and their commitment to life-changing research, visit their official website at www.cenexelresearch.com.
Dr. Singh, who joined the former Advanced Memory Research Institute in September 2019, has played a pivotal role in conducting groundbreaking research aimed at addressing Alzheimer's disease. His background is robust; after graduating from Rutgers University, he attended Rowan Medical School, subsequently becoming a board-certified Emergency Medicine physician at Ocean Medical Center in Brick, New Jersey. This unique blend of experience equips Dr. Singh perfectly for his new leadership role at the Toms River site.
As the primary Principal Investigator, Dr. Singh's responsibilities encompass a wide array of critical functions essential for successful clinical trials. These include ensuring patient safety, guaranteeing the quality of care provided during trials, executing protocols, managing site operations, and fostering collaboration with sponsors and research teams. His leadership is crucial for maintaining the site’s reputation for excellence in clinical research.
"I am honored to lead the Toms River site," Dr. Singh stated in a press release. "CenExel is renowned for its excellence in the research space, and I look forward to continuing that with the team and expanding access to research opportunities for our patient population." His vision aligns seamlessly with CenExel's mission to enhance research access and bolster its presence in New Jersey, particularly addressing pressing health concerns like Alzheimer’s.
The Toms River site is auspiciously positioned as the largest Alzheimer's disease clinical research site in the Northeast, marking it as a significant player in the field of memory disorder research. With its expansive scale, expert staff, and deep patient connections, it serves as a vital component of CenExel's growing clinical research network.
CenExel itself has gained a reputation as a leading entity in supporting the life sciences industry through the discovery and development of transformative therapies. Their commitment is reflected in their comprehensive approach to clinical trials, where they blend scientific expertise with world-class Principal Investigators, advanced patient engagement strategies, and superior data management.
Having conducted thousands of studies with a focus on quality and efficiency, CenExel locations, including Toms River, ensure that research projects are executed quickly and accurately. Their unwavering commitment to patient experience and client success underscores the company’s dedication to delivering impactful clinical outcomes.
With Dr. Arun Singh at the helm, the Toms River site is poised for significant advancements in Alzheimer's research and clinical trials, ultimately contributing to better patient outcomes at both the local and national levels. To learn more about CenExel and their commitment to life-changing research, visit their official website at www.cenexelresearch.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.